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promoters for high level transgene expression in cynomolgus monkeys. 
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Abstract 
Nonhuman primates (NHPs) are considered to be the most valuable models for human 
transgenic (Tg) research into disease, because human pathology is more closely 
recapitulated in NHPs than rodents. Previous studies have reported the generation of Tg 
NHPs that ubiquitously overexpress a transgene using various promoters, but it is not yet 
clear which promoter is most suitable for the generation of NHPs overexpressing a 
transgene ubiquitously and persistently in various tissues. To clarify this issue, we 
evaluated four putative ubiquitous promoters, cytomegalovirus (CMV) immediate-early 
enhancer and chicken beta-actin (CAG), Elongation factor 1 (EF1), Ubiquitin C 
(UbC), and CMV, using an in vitro differentiation system of cynomolgus monkey 
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embryonic stem cells (ESCs). While the EF1 promoter drove Tg expression more 
strongly than the other promoters in undifferentiated pluripotent ESCs, the CAG 
promoter was more effective in differentiated cells such as embryoid bodies and 
ESC-derived neurons. When the CAG and EF1 promoters were used to generate green 
fluorescent protein (GFP)-expressing Tg monkeys, the CAG promoter drove GFP 
expression in skin and hematopoietic tissues more strongly than in F1-GFP Tg 
monkeys. Notably, the EF1 promoter underwent more silencing in both ESCs and Tg 
monkeys. Thus, the CAG promoter appears to be the most suitable for ubiquitous and 
stable expression of transgenes in the differentiated tissues of Tg cynomolgus monkeys 
and appropriate for the establishment of human disease models. 
Introduction 
Many animal models have been created to better understand human diseases and to 
develop novel therapies. Rodents have been used as model organisms for decades, 
because they share common anatomical and pathophysiological features with humans in 
the nervous, cardiovascular, and other internal organ systems [1], and rodent disease 
models are relatively easy to be generated by pronuclear microinjection of a transgene [2], 
by genome-engineered embryonic stem cells (ESCs) [3,4] and by genome editing in 
fertilized oocytes [5,6]. However, rodents do not always recapitulate human disease 
conditions. For example, although humans suffering from Parkinson Disease (PD) show 
spontaneous degeneration of dopaminergic neurons in the substantia nigra and behavioral 
abnormalities, mice lacking a causative gene of familial PD such as Parkin, Pink1 [7], 
Dj-1 [8] and Lrrk2 [9] show no abnormalities in dopamine-related behavior [7,8,10,11]. 
Even triple gene knockout mice lacking Parkin, DJ-1 and Pink1 have normal 
morphology and numbers of dopaminergic and noradrenergic neurons in the substantia 
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nigra [12]. Moreover, transcriptomes exhibit substantial differences between mice and 
humans; thus, more than 20% protein-coding genes are not orthologous (reviewed by 
[13]). Another study clearly showed that the genetic and cellular mechanisms of human 
germ cell development are substantially different from rodents [14]. Therefore, animal 
models to recapitulate human development and disease phenotypes more faithfully are 
needed [15]. 
Nonhuman primates (NHPs) are considered to be the most valuable models for 
human diseases, because NHPs are closer to humans in terms of physiology [16], 
neurology [17] and genetics [18] than rodents. NHPs comprise the New World and Old 
World monkeys. The former includes common marmosets (Callithrix jacchus); the latter 
includes macaques such as cynomolgus monkeys (Macaca fascicularis), rhesus monkeys 
(Macaca mulatta), and Japanese monkeys (Macaca fuscata). Macaques are closer 
genetically to humans than marmosets [19]. To create NHP models of human diseases, 
transgenic (Tg) monkeys have been created by using various promoters in viral-based 
vectors [20–24]. When the elongation factor 1 alpha (EF1 promoter was used to 
introduce the gene encoding green fluorescent protein (GFP) into rhesus monkeys, GFP 
expression was detected only in the placenta and umbilical cord, but it was not detected in 
fetal tissues [20,23]. Niu et al. used the human ubiquitin C (UbC) promoter to 
overexpress GFP and obtained Tg rhesus monkeys expressing GFP in the skin 
successfully [21]. Sasaki et al. tried to create Tg marmosets with a cytomegalovirus 
(CMV) immediate-early enhancer and chicken beta-actin (CAG) promoter, a CMV 
promoter and EF1 promoter, and obtained CAG-GFP-Tg and CMV-GFP-Tg animals 
overexpressing GFP in blastocysts and various tissues [22]. Tomioka et al established a 
tetracycline-induced transgene expression system in marmosets [24]. However, it is not 
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clear which promoter is most suitable for persistent and ubiquitous overexpression in 
undifferentiated and differentiated tissues of Tg NHPs. 
Here, we aimed to clarify promoters suitable for ubiquitous and stable Tg 
overexpression in the tissues of cynomolgus monkeys. We evaluated four ubiquitously 
used promoters—CAG, EF1, UbC and CMV—by combining cynomolgus monkey 
embryonic stem cells (ESCs) with targeted knock-in of a promoter into the 
Adeno-Associated Virus Integration Site 1 (AAVS1) locus and using an in vitro ESC 
differentiation system. Whereas the EF1 promoter drove transgenic expression more 
strongly than other promoters in undifferentiated pluripotent ESCs, the CAG promoter 
was more effective in differentiated cells such as embryoid bodies and ESC-derived 
neurons. The CAG promoter drove GFP expression more strongly than the F1 
promoter in the skin and hematopoietic tissues of Tg animals, but less strongly than the 
F1 promoter in blastocysts. The EF1 promoter was also susceptible to epigenetic 
silencing in both ES cells and animals. These data show that the CAG promoter is most 
suitable for the ubiquitous and stable expression of transgenes in undifferentiated and 
differentiated tissues of Tg cynomolgus monkeys.  
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Materials and Methods  
Construction of targeting vector for ESCs 
Plasmids expressing humanized CRISPR-associated protein 9 
(hCas9) and single guide (sg)RNA (5′-CAC CTA TAA GGT GGT CCC GGC TCT-3′, 
5′-CAC CGA GGA CCG ATT AAT ATG GCT C-3′) were prepared by ligating oligos 
into the BbsI restriction enzyme site of pX330 (http://www.addgene.org/42230/) [25]. 
The donors 
(pBR-monkeyAAVS1-FRT-SA-IZpA-FRT-Rev_CAG_EGFP_pA-MC1DTApAII, 
pBR-monkeyAAVS1FRT-SA-IZpA-FRT-Rev_EF1_EGFP_pA-MC1DTApAII, 
pBR-monkeyAAVS1-FRT-SA-IZpA-FRT-Rev_UbC_EGFP_pA-MC1DTApAII and 
pBR-monkeyAAVS1-FRT-SA-IZpA-FRT-Rev_CMV_EGFP_pA-MC1DTApAII) were 
constructed by introducing the left homology arms of the AAVS1, FRT, SA, IRES, 
Zeocin-resistant gene, promoter (CAG, EF1, UbC or CMV) GFP cDNA and right 
homology arm sequences into the XhoI and NotI restriction enzyme sites of the 
pBRMC1DTApAII plasmid. This was provided by Dr. Hitoshi Niwa (Kumamoto 
University). 
Establishment of a cynomolgus monkey ES cell line 
For establishment of a cynomolgus monkey embryonic stem cell line (Cyn ESC #3X), 
blastocysts were produced by intracytoplasmic sperm injection (ICSI) followed by in 
vitro culture for 8 days. ICSI and embryo culture were carried out as described by Seita et 
al. [26]. Inner cell masses (ICMs) were isolated by mechanical cutting using a needle. 
The ICMs were plated onto mouse embryonic fibroblast (MEF) feeder cells and cultured 
in embryonic stem (ES) cell medium as described below. After expanding ICMs, the 
primary colonies were dissected mechanically and transferred to feeder layers. After 
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several passages, the expanded cells were dissociated with TrypLE Select (Thermo 
Fisher Scientific 12563029) for further expansion. Karyotyping was carried out by 
Chromosome Science Labo Inc. (Sapporo, Japan), which showed that all 50 examined 
cells had the normal 42XX karyotype. For the analysis of in vivo differentiation ability, 5 
 105 ESCs were injected under the testicular capsules of severe combined 
immunodeficiency mice. Eight weeks after injection, teratomas were recovered and fixed 
with Bouin’s fluid. Histology of prepared sections was performed using hematoxylin and 
eosin staining. 
ES cell culture 
Briefly, cynomolgus monkey ESCs were maintained on mitomycin C-treated MEF 
feeder cells in DMEM/F12 GlutaMax medium (Thermo Fisher Scientific, 10565-018) 
containing 10 ng/ml bFGF (Wako 6805384), 20% (v/v) KSR (Thermo Fisher Scientific, 
10828028), NEAAs (Thermo Fisher Scientific, 11140-050), penicillin/streptomycin 
(Thermo Fisher Scientific 15140-122), 0.1 mM -mercaptoethanol (Sigma-Aldrich 
M3148), and 10 µM XAV939 (Calbiochem 575545). For routine maintenance, cells 
were prepared for passaging every 5–7 days as single cell suspensions using TrypLE 
Select and seeded at a density of 1  104 cells/9 cm2. The culture medium was 
supplemented with 10 µM ROCK inhibitor (Wako 253-00513) until 24 h after 
passaging. Two-hundred microliters of serum-free cell-freezing medium, BamBanker 
(Nippon Genetics CS-02-001), was used to cryopreserve aliquots of 1–5  105 cells. 
To establish knock-in ESC lines, 2  104 ESCs were transfected simultaneously 
with circular forms of 1 µg targeting vector and 1 µg pX330 using Lipofectamine 2000 
(Thermo Fisher Scientific). Transfected cells were seeded on MEFs. After 7–10 days 
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culture, GFP-positive primary colonies were picked out, dissociated with TrypLE Select 
and transferred onto fresh MEF layers in 48-well plates. When GFP-positive colonies 
did not appear, 96 colonies were picked up randomly, and PCR genotyping was carried 
out with primers as shown in Table S1 to obtain colonies in which the target gene was 
properly knocked in. 
Embryoid body formation 
After the passage period, 3,000 or 4,000 cells were suspended in EB medium 
(DMEM/F12 GlutaMax containing 20% (v/v) KSR, NEAA, Penicillin/Streptomycin, 
0.1 mM -Mercaptoethanol and 10 µM ROCK inhibitor), and aggregated in 
low-cell-binding V-bottom 96-well plates (Greiner Bio-one International 651970). The 
medium was not changed until the analysis at 8 days of induction. Images of the 
aggregates were taken using a Biorevo inverted microscope (Keyence). The aggregates 
were collected at the designated days for RNA, immunohistochemistry (IHC) and 
FACS analysis. For IHC, the aggregates were embedded in iPGell (GenoStaff), fixed 
with 4% paraformaldehyde (PFA), embedded in OCT compound, frozen in liquid 
nitrogen, cut into 10 µm-thick sections, and placed on glass slides that were treated with 
Blocking One (Nacalai Tesque) for 30 min at room temperature. Primary antibodies 
used are listed in Table S2. Labeled proteins were detected with appropriate secondary 
antibodies. Nuclei were counterstained with Hoechst 33342 (Thermo Fisher Scientific, 
H3570). Cells were then observed under a TCS SP8 confocal microscope (Leica). 
For FACS analysis, after washing once with phosphate-buffered saline (PBS), 
the aggregates were dissociated by treatment with 0.25% trypsin-EDTA (Thermo Fisher 
Scientific) for 10–20 min at 37 °C and then dispersed by gentle pipetting. After washing 
with PBS containing 10% (v/v) fetal bovine serum (FBS, Sigma-Aldrich, 172012) and 
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0.1% bovine serum albumin (BSA, Sigma-Aldrich, A7906), the cells were suspended in 
FACS buffer (0.1% BSA in PBS) and passed through a cell strainer (BD Biosciences) to 
remove cell clumps. The numbers of cells per aggregate were counted and they were 
washed once with PBS and processed using a FACSCalibur instrument (BD 
Biosciences) for analysis and sorting.  
GFP protein expression levels in CK8-positive endoderm cells or 
MSX1-positive mesoderm cells of EBs were analyzed as described [27]. Briefly, mean 
fluorescence intensities inside regions of interest were measured and subtracted from 
background signals, which were defined as the mean fluorescence intensities of 
randomly chosen cytoplasmic signals, and then normalized against the mean 
fluorescence intensities in the Hoechst channel using ImageJ ver. 1.51 image analysis 
software (National Institutes of Health, Bethesda, MD; https://imagej.nih.gov/ij/).  
Neuronal differentiation 
During the passage period, 3,000 or 4,000 cells were suspended in EB medium and 
aggregated in low-cell-binding V-bottom 96-well plates. On the second day after 
aggregation, the medium was changed from EB medium to neural differentiation 
medium. This had the same formulation as EB medium, with the addition of 1 µM 
retinoic acid (Wako 186-0114), 3 µM dorsomorphin (Wako 041-33763), 3 µM 
SB431542 (Wako 031-24291) and 3 µM BIO: 6-Bromoindirubin-3-oxime (Wako 
029-16241). After 4 days of aggregation, the medium was changed from neural 
differentiation medium to culture medium without dorsomorphin, SB431542 or BIO but 
with 1 µM purmorphamine (Wako 166-23991). After 14 days of differentiation, the 
aggregated cells were trypsinized into single cells and plated on Poly-D-Lysine 
(Sigma-Aldrich P1024)-coated glass slides and cultured for a further 5 days. After in 
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vitro neural differentiation, the cells were subjected to IHC with anti-SYNAPSIN I and 
anti-III-TUBULIN antibodies listed on Table S2. 
Animals 
All experimental procedures were approved by the Animal Care and Use Committee of 
Shiga University of Medical Science and methods were carried out in accordance with 
the approved guidelines (Approval number: 2016-12-5(H1)). Oocytes were collected 
from eight sexually mature female cynomolgus monkeys, aged 4–8 years and weighing 
2.1–3.9 kg. Twenty sexually mature females aged 4 years old and weighing 2.0–3.8 kg, 
were used as recipients. Semen was collected from one sexually mature male monkey, 
aged 12 years and weighing 6.2 kg as described by Sankai et al. [28] with a minor 
modification. In brief, fresh spermatozoa were collected by direct electric stimulation (5–
15 V, 1 pulse/sec) of the penis without anesthesia. For de-coagulation, ejaculated semen 
was placed in a disposable plastic tube and incubated at 37°C for 30 min. The semen was 
transferred into a new disposable plastic tube and diluted with 10 ml Biggers, Whitter, 
and Whittingham medium (BWW) containing 1 mM caffeine, 1 mM dbcAMP, and 0.3% 
BSA, and incubated at 37°C for 30 min. Then, the diluted semen was centrifuged at 380 × 
g for 5 min at room temperature to wash the semen. The supernatant was removed, and 
then 1 ml BWW containing 1 mM caffeine, 1 mM dbcAMP, and 0.3% BSA was added to 
the semen pellet. Spermatozoa that swam up from for the semen pellet were used for 
ICSI.  
Temperature and humidity in the animal rooms were maintained at 25 ± 2 °C 
and 50 ± 5%, respectively. The light cycle was 12 h of artificial light from 08:00 to 20:00. 
In the morning, each animal was fed 20 g/kg of body weight of commercial pellet 
D
ow
nloaded from
 https://academ
ic.oup.com
/biolreprod/advance-article-abstract/doi/10.1093/biolre/ioz040/5380771 by Shiga Ika U
niversity user on 27 M
arch 2019
monkey chow (CMK-1; CLEA Japan), supplemented with 20–50 g of sweet potato in the 
afternoon. Water was available ad libitum. 
Lentiviral vector construction 
pCSII-CAG-EGFP was constructed by introducing the CAG promoter from pCAGGS 
and GFP cDNA into pCSII-EF-MCS-IRES2-Venus plasmid. pCSII-EF1-EGFP was 
constructed by introducing GFP cDNA into pCSII-EF-MCS-IRES2-Venus plasmid. 
pCAGGS was provided by Dr. Hitoshi Niwa (Kumamoto University). 
Production of transgenic cynomolgus monkeys 
Oocyte collection, lentiviral transduction, virus injection to embryos, ICSI, embryo 
transfer, pregnancy detection and observation of green fluorescence in Tg offspring were 
carried out as described by Seita et al. [26] The eight oocyte donors each received 
subcutaneous injection of human follicle-stimulating hormone (15 IU/kg, Asuka 
Pharmaceutical) via a micro-infusion pump (iPRECIO SMP-200, ALZET Osmotic 
Pumps) at 7 µl/h for 10 days. On day 10, the animals received an intramuscular injection 
of human chorionic gonadotropin (Puberogen, Nippon Zenyaku Kogyo), and oocytes 
were aspirated laparoscopically after 40 h. The recovered meiosis (M)-II-stage oocytes 
containing the first polar body were placed in m-TALP, a modified Tyrode’s solution 
containing HEPES, and injected with lentivirus, ICSI was performed 3–4 h after virus 
injection. The fertilized oocytes were cultured in CMRL Medium-1066 (Thermo Fisher 
Scientific, 11530-037) containing 20% (v/v) FBS. When embryos developed to 
blastocysts, one embryo was transferred into each female recipient. 
Southern blotting 
Five microgram aliquots of genomic DNA were digested with EcoRI and the digested 
genomic DNA was separated on a 0.8% agarose gel and transferred to a Hybond-N+ 
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nylon membrane (GE Healthcare Biosciences). Southern blot analysis was performed 
using the digoxigenin (DIG) system (Roche Diagnostics K.K.), according to the 
manufacturer’s protocol. The GFP DNA probe was labeled by amplification in the 
presence of DIG using the PCR DIG probe synthesis kit. 
Immunohistochemistry 
Blastocysts were fixed in 4% PFA at room temperature for 30 min and treated with 
Blocking One (Nacalai Tesque) for 30 min at room temperature. Primary antibodies and 
dilutions used were listed on Table S2. GFP protein expression levels in the blastocysts 
were analyzed as described previously [27]. Briefly, mean fluorescence intensities 
inside regions of interest were measured and subtracted from background signals, which 
were defined as average of mean fluorescence intensities of random chosen cytoplasmic 
signals, and were then normalized against the mean fluorescence intensities in the 
Hoechst channel using ImageJ image analysis software as above 
Tissues were fixed in 4% PFA at 4 °C overnight, embedded in OCT compound, 
frozen in liquid nitrogen, cut into 5- or 10-µm sections, placed onto glass slides and 
treated with Blocking One solution for 30 min at room temperature. Primary antibodies 
and dilutions were listed on Table S2. Labeled proteins were detected by appropriate 
secondary Alexa Fluor 594-labeled antibodies. Tissues were counterstained with 
Hoechst 33342 and the images were taken using the TCS SP8 confocal microscope. 
RT-qPCR 
Total RNA was extracted from cells or tissues using RNeasy Mini kits (Qiagen). For 
reverse transcription, ReverTra Ace (Toyobo TRT-101) and oligo (dT) 20 primers were 
used. THUNDERBIRD SYBR qPCR Mix (Toyobo QPS-101) was used for qPCR. 
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Transcript levels were determined in triplicate reactions and normalized against the 
corresponding levels of GAPDH. Primer sequences used are shown in Table S1. 
Flow cytometry analysis 
0.5 ml blood was collected from the femoral vein using a 27-gauge needle and 
centrifuged at 1,730 × g for 5 min to separate whole blood cells. Hemolysis was 
performed with Lysing buffer (BD Pharm. 555899) to collect mononuclear cells. These 
cells were washed with PBS and suspended in PBS + 2% (v/v) FBS. The pellet was 
incubated with mouse Alexa Fluor 647-conjugated anti-human CD20 (1:10, BioLegend 
302318), mouse phycoerythrin-conjugated anti-human CD3 (1:10, BD 552127), and 
allophycocyanin-conjugated anti-mouse/human CD11b (1:100, BioLegend 101212) 
antibodies for 1 h on ice. Samples were washed with PBS and resuspended in 300 µl 
PBS containing 0.1 mg/ml propidium iodide. Flow cytometry analysis was then 
performed using a FACSCalibur instrument (BD Biosciences). 
Statistical analysis 
Statistical analyses of all data comparisons were carried out by multiple one way analysis 
of variance (ANOVA) using GraphPad Prism 8 software 
(https://www.graphpad.com/scientific-software/prism/). P < 0.05 was considered as 
statistically significant. 
Results 
Evaluation of various ubiquitous promoters in undifferentiated ESCs 
Although previous studies reported the generation of transgenic NHPs that ubiquitously 
overexpress a transgene such as that encoding GFP by utilizing various promoters [20–
22,29], it is not clear which promoter is most suitable for persistent and ubiquitous 
overexpression in undifferentiated and differentiated tissues of NHPs. Therefore, we 
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aimed to clarify suitable promoters for ubiquitous and stable Tg overexpression in the 
tissues of cynomolgus monkeys. In particular, we paid attention to the level and extent of 
expressions driven by a promoter and its persistent expression (i.e., resistance to the 
silencing of Tg expression). 
Although we have generated GFP-expressing Tg cynomolgus monkeys and 
showed that the CAG promoter drives transgene expression in most cells of various 
tissues [26], there are inherent difficulties in the evaluation of promoter activities using 
such models; thus, the copy number of the lentiviral vector and its integration site into the 
genome are not easily controlled, and animal experiments must be restricted because of 
the high ethical standards required by NHP studies. Therefore, we aimed to develop an in 
vitro assay system to evaluate promoter activities in undifferentiated and differentiated 
cynomolgus monkey ESCs. To compare promoter activities under the same experimental 
condition, we tried to introduce a promoter-GFP knock-in donor into the first intron of the 
AAVS1 locus, which is often used as a safe harbor [30–32], in cynomolgus monkey 
ESCs (Fig.1A), thereby enabling us to measure promoter activity under identical 
chromosome positions and copy numbers. First, we established a novel cynomolgus 
monkey ESC line (Fig. 1B) and checked the karyotyping by G-banding and pluripotency 
by teratoma formation ability (Fig. 1C, D). PCR analysis showed that AAVS1 locus 
were correctly targeted with respective promoter-GFP knock-in vector, and the 
heterozygous knock-in ESC lines were established (Fig.1E). We examined GFP 
protein expression and found the strongest GFP fluorescence in EF1-GFP ESCs under 
undifferentiated condition (Fig.1F), whereas the CAG and UbC promoters were second 
and third strongest, respectively (Fig.1F). Unexpectedly, the CMV promoter showed no 
detectable activity (Fig. 1F). Fluorescence-activated cell sorting (FACS) and RT–qPCR 
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analysis also showed the strongest GFP expression was driven by the EF1 promoter 
(Fig. 1G–I), although there were GFP-negative cells (24.3%) in EF1-GFP ESCs (Fig. 
1G). Because the CMV promoter was unexpectedly inactive, we introduced the 
promoter-GFP knock-in donor vectors used for targeting experiments into 293FT cells 
transiently and found that the CMV promoter was highly active in this situation (Fig. S1). 
Taken together, the EF1 promoter proved most suitable for a high level of 
overexpression in undifferentiated pluripotent stem cells; the CAG and UbC promoters 
were suitable as second and third choices, respectively. 
Evaluation of promoters in embryoid bodies (EBs) harboring three germ 
layer-derived tissues 
To evaluate promoter activities in differentiated cells, EBs harboring three germ 
layer-derived tissues were prepared in floating culture in the absence of basic fibroblast 
growth factor (bFGF) (Fig. 2A) as described [33]. ESCs formed ball-shaped structures in 
the suspension culture for 8 days. Semiquantitative PCR analysis indicated that the 
pluripotency markers, OCT4 and NANOG, decreased rapidly, and the endoderm markers, 
CK8 and CK18, the mesoderm markers, T (BRACHYURY) and MSX1, and ectoderm 
markers, PAX6 and MAP2, increased, indicating that the EBs had differentiated 
successfully into all three germ layers (Fig. 2B). AAVS1
+/CAG-GFP
 (AAVS1-CAG-GFP) 
EBs at day 8 showed the strongest fluorescence, and AAVS1
+/EF1-GFP
 
(AAVS1-EF1-GFP) EBs and AAVS1+/UbC-GFP (AAVS1-UbC-GFP) EBs showed 
moderate fluorescence. No fluorescence was observed in AAVS1
+/CMV-GFP
 
(AAVS1-CMV-GFP) EBs (Fig. 2C). FACS analysis showed a high percentage of 
GFP-positive cells in AAVS1-CAG-GFP (94.5%) and AAVS1-UbC-GFP
 
(98.9%) EBs 
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at day 8, compared with those of AAVS1-EF1-GFP EBs (72.8%) and 
AAVS1-CMV-GFP EBs (0.57%) (Fig. 2D). The fluorescence intensity of 
AAVS1-CAG-GFP EBs was 1.3 times stronger than that of AAVS1-EF1-GFP and 2.3 
times stronger than that of AAVS1-UbC-GFP
 
EBs at day 8 of culture (Fig. 2E). RT–
qPCR analysis showed that GFP mRNA expression in AAVS1-CAG-GFP EBs increased 
significantly as the tissues differentiated, while GFP mRNA expression in 
AAVS1-EF1-GFP EBs decreased remarkably (Fig. 2F). However, the GFP mRNA 
expression level in AAVS1-UbC-GFP EBs showed no significant change (Fig. 2F). We 
also examined GFP expression levels in CK8-positive endoderm cells and MSX1-positive 
mesoderm cells in the EBs at day 8 (Figs. 2G, H, S2). We found that the CAG promoter 
had strong and uniform activity in both CK8- and MSX-positive cells (Figs. 2G, H, S2), 
while the EF1 promoter showed bimodal expressions in these cells; strong and 
weak/negative, respectively. The UbC promoter had moderate and uniform activity in 
both CK8- and MSX1-positive cells (Figs. 2G, H, S2), while the CMV promoter activity 
was very weak in these cells.  
Promoter activities in ESC-derived neurons 
To evaluate promoter activities in ES-derived neurons, ESCs were differentiated into 
neurons according to the dual inhibition method [34] (Fig. 3A). RT–qPCR and 
immunohistochemistry (IHC) showed that III TUBULIN and SYNAPSIN I expressions 
were induced during the course of EB differentiation (Fig. 3B), indicating successful 
differentiation of the ESCs into neurons. AAVS1-CAG-GFP ESCs showed strongest 
GFP fluorescence (Fig. 3C), while AAVS1-EF1-GFP and AAVS1-UbC-GFP ESCs 
showed moderate signals, and AAVS1-CMV-GFP ESCs showed no detectable 
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fluorescence (Fig. 3C). Consistent with these observations, the mean intensities of 
GFP-positive cells in FACS analysis of the EBs at day 14 and the results of RT–qPCR 
analysis showed that the CAG promoter showed the strongest signal (Fig. 3D, E). 
FACS analysis showed that most if not all of the III TUBULIN-positive neurons in 
AAVS1-CAG-GFP EBs were strongly GFP-positive (98.1%)(Fig. 3F), while 
AAVS1-EF1-GFP EBs were GFP-positive (65.8%) with a substantial proportion of 
negative cells (33.5%), AAVS1-UbC-GFP EBs were GFP-positive (93.1%), but the 
intensity was weaker than that of AAVS1-CAG-GFP EBs, AAVS1-CMV-GFP EBs were 
almost entirely GFP-negative (99.6%) (Fig. 3F). At 19 days, most of the SYNAPSIN 
I-positive neurons from AAVS1-CAG-GFP ESCs co-expressed GFP strongly (Fig. S3), 
while SYNAPSIN I-positive neurons from AAVS1-EF1-GFP ESCs showed bimodal 
GFP expression with GFP-negative cells (Fig. S3; the cells indicated by arrows). Thus, 
the CAG promoter proved the most suitable for persistent and high level transgenic 
expression in differentiated cells. 
Production of GFP Tg cynomolgus monkeys with CAG and EF1 promoters 
Because the CAG and EF1 promoters drove transgenic expression most strongly in 
differentiated and undifferentiated cells, respectively, we constructed lentiviral vectors 
carrying the gene encoding GFP under the control of these promoters (Fig. 4A) and 
injected them into oocytes. Eight days after fertilization, the blastocysts infected with 
EF1-GFP lentivirus showed stronger GFP fluorescence than did those treated with the 
CAG-GFP lentivirus (Fig. 4B), consistent with the notion that the EF1 promoter drives 
stronger Tg expression in undifferentiated ESCs than does the CAG promoter (Fig. 1F–I). 
After transfer to recipient foster mothers, we obtained three CAG-GFP Tg and three 
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EF1-GFP Tg offspring (Fig. 4C, Table S3). We estimated the copy numbers of 
transgenes by Southern blot analysis as follows (Fig. S4): CAG-GFP Tg monkeys 
(CE1894M, 1 copy; CE1993F, 5 copies; CE1984F, 5 copies) and EF1-GFP Tg monkeys 
(CE1881M 4 copies; CE1886M 11 copies; and CE1887F, 8 copies). GFP fluorescence 
was observed on the facial skin of the CAG-GFP CE1894M, CE1993F and CE1984F Tg 
offspring, while GFP fluorescence was not detected on the facial skin of the EF1-GFP 
Tg monkey (CE1881M), and GFP fluorescence was observed on the facial skin of the 
CE1886M and CE1887F. It is notable that GFP fluorescence was detected in a CAG-GFP 
Tg monkey carrying just one copy of the gene for GFP (CE1894M), whereas it was not 
detected in the EF1-GFP Tg monkey carrying four copies of the transgenes (CE1881M) 
(Figs. 4C, S4). Consistent with our finding that the CAG promoter drove transgenic 
expression more strongly than the EF1 promoter in ESC-derived differentiated cells 
(Figs. 2, 3, S3), activity of the CAG promoter was overall stronger in the skin than that of 
the EF1 promoter (Fig. 4). 
GFP expression in the skin tissues of Tg animals 
Although GFP fluorescence intensity of facial skin in the CAG-GFP Tg monkey was 
overall stronger than that of the EF1-GFP Tg monkey, we investigated the expression 
of GFP at a cellular level in back skin biopsies (Fig. 5). IHC showed that GFP 
expression could be detected in the hair roots of three CAG-GFP Tg offspring 
(CE1894M, CE1993F, and CE1984F), and that the intensity increased with the 
transgene copy number (Figs. 5A, S4). However, the EF1-GFP Tg, monkey 
(CE1881M) did not show detectable GFP signals in the hair follicle, even though it 
carried four copies of the transgene (Figs 5A, S4). The CE1886M and CE1887F showed 
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small numbers of GFP-positive cells in the hair follicles (Figs. 5A, S4). Consistent with 
the GFP protein expression in skin tissues, RT–qPCR analysis showed that GFP mRNA 
expression was abundant in the skin of CAG-GFP Tg monkeys but at a low level in the 
EF1-GFP Tg monkeys (Fig. 5B). Overall, these data showed that GFP expression 
levels in the skin tissues of CAG-GFP Tg monkeys were considerably stronger than in 
EF1-GFP Tg monkeys, although the exact copy numbers and chromosomal integration 
sites of the transgenes were not controlled precisely.  
GFP expression in the blood cells of Tg animals 
Since we investigated promoter activities in the skin that is derived from ectoderm, we 
investigated peripheral blood cells originating from mesoderm. FACS analysis clearly 
showed that the percentage of GFP-positive cells in T-cells (CD3+), B-cells (CD20+), 
granulocytes (CD11+/SSC high) and monocytes (CD11+/SSC low) were higher than 
those of EF1-GFP Tg cells in CAG-GFP Tg monkeys (Fig. S5). The percentage and 
fluorescence intensity of GFP-positive peripheral blood cells tended to increase as the 
GFP transgene copy number increased, in both CAG-GFP Tg and EF1-GFP Tg 
monkeys (Fig. S5). Taken together, the CAG promoter proved more suitable to drive 
transgene expression in hematopoietic cells at high levels than the EF1promoter.  
In summary, our results indicate that the CAG promoter is most suitable for 
stable, ubiquitous and high-level expression of transgenes in ESC-derived 
differentiated cells and tissues of cynomolgus monkeys (Fig. 6). The EF1 promoter is 
suitable for high expression of transgenes in undifferentiated ESCs and blastocysts, but 
it undergoes silencing (Fig. 6). The UbC promoter is suitable for stable, ubiquitous, 
and moderate expression of transgenes in ESC-derived differentiated cells (Fig. 6). 
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Discussion 
Because NHPs share similar developmental paths with humans in their anatomy, 
physiology and genetics [35], there has been growing interest in human disease models 
using genetically modified NHPs [21,36,37]. However, it is not yet clear which promoter 
is most suitable to create Tg animals with ubiquitous and persistent overexpression of a 
transgene in their tissues. Given the fundamental ethical dilemma concerning the use of 
NHPs in biomedical research [35], we tried to substitute animal experiments with in vitro 
ESC differentiation. The AAVS1 locus of cynomolgus monkey ESCs was targeted with 
four well-known promoters: CAG, EF1, CMV and UbC, which are frequently used in 
other animal species [38–41]. Our study clearly demonstrated that the EF1promoter 
drove the strongest Tg expression in undifferentiated cynomolgus monkey ESCs, and 
that the CAG and UbC promoters were second and third in efficacy, respectively. This 
finding was consistent with a previous report by Xia et al., where the descending order 
of promoter activity was EF1CAG, and CMV [42] in undifferentiated human ESCs. 
Our study also clearly demonstrated that CAG promoter drove Tg expression 
ubiquitously at the highest level in EBs and ES-derived neurons without detectable 
epigenetic silencing, consistent with the report by Jakobsson et al., that the CAG 
promoter among three tested (CMV, EF1 and CAG) achieved a high level of GFP 
expression in the striatum and white matter of the brain [43]. The EF1 promoter drove 
transgene expression at the highest level in most of undifferentiated ESCs, but lost its 
activity in some cells. Potentially, an epigenetic silencing mechanism, which was 
proposed previously, occurred in our ES cells and tissues of Tg animals [26], although 
the exact mechanism is unclear. As ESCs differentiated, the Tg expression was reduced 
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gradually, consistent with a report that the EF1 promoter suffers from gradual 
silencing in mouse and human ESCs [44,45]. Our finding that GFP expression was not 
detectable in EF1α-GFP Tg monkeys with four copies of the transgene might have arisen 
in part from silencing of the corresponding genomic regions is inherently difficult 
because the blastocysts did not use the safe harbor approach. 
Mosaicism is an issue to be considered when Tg animals are generated by 
virus-mediated approaches [46,47], because viral DNA may be integrated into the 
genome after the first cleavage, even though the virus infects fertilized eggs. Such 
mosaicism may in part explain our results, i.e. the differences in the band intensities of 
our Southern blot and the GFP-negative cells in Tg monkey tissues.   
Transgenic animals ubiquitously overexpressing a transgene (e.g., that encoding 
GFP) have been widely used in biomedical research including bone marrow 
transplantation. In general, a line of Tg animals carrying a single integration of a 
transgene in a chromosome is used, because the line can be expanded by mating, and the 
level and pattern of GFP expression in various tissues is identical—in principle—among 
the individuals suitable for experimental reproducibility. In this regard, the CAG-GFP Tg 
monkey should be a promising founder animal for future generations, because even a 
single copy of the CAG-GFP transgene could label most if not all cells in various tissues, 
while other Tg monkeys carry multiple copies of transgenes and each transgene needs to 
be segregated. It is of note that a single copy of the EF1-GFP transgene seems to be 
insufficient to drive GFP expression in skin and hematopoietic tissues. 
Taken together, our study clearly demonstrates that the CAG promoter is the 
best option to achieve ubiquitous and stable expression of transgene in the tissues of 
cynomolgus monkeys used for human disease modeling. We also suggest that in vitro 
D
ow
nloaded from
 https://academ
ic.oup.com
/biolreprod/advance-article-abstract/doi/10.1093/biolre/ioz040/5380771 by Shiga Ika U
niversity user on 27 M
arch 2019
ESC differentiation systems can substitute significantly for animal experiments using 
NHPs. 
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Figure 1. Generation of 
AAVS1-CAG-GFP/AAVS1-EF1-GFP/AAVS1-UbC-GFP/AAVS1-CMV-GFP 
ESCs 
A. Schematic overview depicting the targeting strategy for the cynomolgus monkey 
AAVS1 locus. Arrow, genomic site cut by the respective CRISPR pair. Shown above 
is a schematic of the donor plasmid design. Donor plasmids were created 
corresponding to the cleavage location of the CRISPR pair and transferred roughly 
1,500-bp regions of homology to the AAVS1 genomic sequence. Red, black, orange, 
and green arrows show primer pairs for genomic PCR. Each primer pair amplified the 
corresponding genomic regions: primer pair 1, 3′ half of the knock-in construct, 3′ 
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arm, and a part of the genomic region outside of the 3′ arm; primer pair 2, 5′ half of 
the knock-in construct, 5′ arm, and a part of the genomic region outside of the 5′ arm; 
primer pair 3, the entire knock-in construct, 5′ and 3′ arms, and a part of the genomic 
region outside of the 5′ and 3′ arms; primer pair 4, a part of the DT-A and MC1 
promoter and 3′ half of the knock-in construct. SA, splice acceptor sequence; Zeo, 
zeocin resistance gene; polyA, polyadenylation sequence; FRT, flippase recognition 
target sequence; IRES, internal ribosome entry site; DT-A, Diphtheria toxin A 
sequence. B. Establishment of cynomolgus monkey ESC line. C. Karyotyping of ESCs. 
D. Teratoma derived from ESCs. HE, Hematoxylin and eosin (HE) staining of a teratoma 
derived from ESCs (Cyn ESC #3X). Scale bars = 300 µm. E. Genomic PCR of 
AAVS1-CAG-GFP, AAVS1-EF1-GFP, AAVS1-UbC-GFP and AAVS1-CMV-GFP 
ESCs. WT, wild-type. F. Fluorescent imaging of GFP in heterozygous 
AAVS1-CAG-GFP, AAVS1-EF1-GFP, AAVS1-UbC-GFP and AAVS1-CMV-GFP 
ESCs. Scale bars = 100 µm. G. FACS analysis of heterozygous AAVS1-CAG-GFP, 
AAVS1-EF1-GFP, AAVS1-UbC-GFP and AAVS1-CMV-GFP ESCs. H. Median GFP 
fluorescence intensity of heterozygous AAVS1-CAG-GFP, AAVS1-EF1-GFP, 
AAVS1-UbC-GFP and AAVS1-CMV-GFP ESCs. Data are shown as the mean of 
median intensities. I. RT–qPCR analysis of heterozygous AAVS1-CAG-GFP, 
AAVS1-EF1-GFP, AAVS1-UbC-GFP and AAVS1-CMV-GFP ESCs. Data are shown 
as the mean ± standard deviation (SD). Asterisks in H and I indicate the statistical 
significance of differences: ****P < 0.0001; ***P < 0.001. 
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Figure 2. Promoter activities in embryoid bodies with all three germ layers 
A. Schematic overview for the random differentiation of ESCs. Shown above is the 
medium for random differentiation of ESCs. Shown below is the timing of cell 
sampling. B. Semiquantitative PCR analyses of various differentiation markers for 
three germ layers. C. Fluorescent images of day 8 EBs from heterozygous 
AAVS1-CAG-GFP, AAVS1-EF1-GFP, AAVS1-UbC-GFP and AAVS1-CMV-GFP 
ESCs. Insets in each panel show brightfield images. Scale bars = 100 µm. D. FACS 
analysis using day 8 EBs from heterozygous AAVS1-CAG-GFP, AAVS1-EF1-GFP, 
AAVS1-UbC-GFP and AAVS1-CMV-GFP ESCs. E. GFP fluorescence intensities in 
day 8 EBs from heterozygous AAVS1-CAG-GFP, AAVS1-EF1-GFP, 
AAVS1-UbC-GFP and AAVS1-CMV-GFP ESCs. Data are shown as means of the 
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median. F. GFP expression levels in day 0 and day 8 EBs from heterozygous 
AAVS1-CAG-GFP, AAVS1-EF1-GFP, AAVS1-UbC-GFP and AAVS1-CMV-GFP 
ESCs evaluated by RT–qPCR. Data are shown as the mean ± SD. G. Violin plot of GFP 
protein expression level of CK8-positive cells in the EBs at day 8. The red dashed line 
indicates the median value and the black dashed lines indicate quartiles. H. Violin plot of 
GFP protein expression level of MSX1-positive cells in the EBs at day 8. The red dashed 
line indicates the median value and the black dashed lines indicate quartiles. Asterisks in 
E, F, G, and H indicate statistical significance: ****P < 0.0001; ***P < 0.001; **P < 
0.01; *P < 0.05  
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Figure 3. Promoter activities in the ESC-derived neurons 
A. Schematic overview for the neuronal differentiation of ESCs. Shown above is the 
medium for neuronal differentiation of ESCs. Shown below is the timing of cell 
sampling. B. Expression of neuronal maker genes during differentiation measured by 
RT–qPCR. C. Fluorescent images of day 14 EBs (upper) and dispersed cells cultured for 
1 day after trypsinization of the EBs (lower) formed by heterozygous AAVS1-CAG-GFP, 
AAVS1-EF1-GFP, AAVS1-UbC-GFP and AAVS1-CMV-GFP ESCs. Insets in each 
panel shows brightfield images. Scale bars = 100 µm. D. Relative GFP fluorescence 
intensities in day 0, day 8 and day 14 EBs from heterozygous AAVS1-CAG-GFP, 
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AAVS1-EF1-GFP, AAVS1-UbC-GFP and AAVS1-CMV-GFP ESCs. Fluorescence 
was measured by FACS analysis. Data are shown as mean ± SD. E. GFP expressions in 
day 0 and day 14 EBs from heterozygous AAVS1-CAG-GFP, AAVS1-EF1-GFP, 
AAVS1-UbC-GFP and AAVS1-CMV-GFP ESCs evaluated by RT-qPCR. Data are 
represented as mean ± SD. N.D., Not detected. Asterisks in D. and E. indicate statistical 
significance: ****P < 0.0001; **P < 0.01; *P < 0.05 F. FACS analyses of III 
TUBULIN/GFP expression of the day 14 EBs from heterozygous AAVS1-CAG-GFP, 
AAVS1-EF1-GFP, AAVS1-UbC-GFP and AAVS1-CMV-GFP ESCs. WT, wild-type.  
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Figure 4. Generation of GFP Tg cynomolgus monkeys 
A. Schematic representation of the lentiviral vector used for generation of GFP Tg 
monkeys. LTR: long terminal repeat. WPRE: woodchuck hepatitis posttranscriptional 
regulatory element. B. Fluorescent images of cynomolgus monkey blastocysts 7 days 
after infection with the lentivirus. Scale bars = 100 µm. Right panel shows Tukey box 
plots of GFP protein expression levels. Cell numbers are shown in brackets. A.U., 
arbitrary unit. Asterisks indicate statistical significance: ***P < 0.001. C. Upper panels 
show bright field images of the faces of CAG-GFP Tg (left) and EF1-GFP Tg (right) 
offspring. Lower panels show fluorescence images of the faces of CAG-GFP Tg (left) 
and EF1-GFP Tg (right) offspring.  
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Figure 5. GFP expressions in the skins of Tg monkeys 
A. Immunohistochemistry of skin tissues from CAG-GFP-Tg (upper panel) and 
EF1-GFP-Tg (lower panel) offspring with anti-GFP and anti-Pan Cytokeratin 
antibodies detected by confocal microscopy. Images were taken under the same 
instrument settings (same laser intensity). Scale bars = 100 µm. B. GFP expression in 
CAG-GFP-Tg and EF1-GFP-Tg offspring by RT–qPCR. Data are shown as the mean ± 
SD. Asterisks indicate statistical significance: ****P < 0.0001; **P < 0.01; *P < 0.05 
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Figure 6. Summary of promoter activity measurements in transgenic cynomolgus 
monkeys and ESCs 
A, B. Schematic of GFP expression in ESCs (A) and embryos (B). In ESCs, the EF1 
promoter drove GFP more strongly than other promoters in pluripotent ESCs, whereas 
the CAG promoter activity was strongest in ESC-derived tissues. However, in the Tg 
cynomolgus monkey, the CAG promoter drove GFP more strongly than the F1 
promoter. Notably, the EF1 promoter underwent more silencing in both ESCs and Tg 
monkeys. C. Relative promoter activity at various stages in Tg tissues. Numbers of + 
symbols indicate GFP expression intensity. N.D., Not determined. 
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